- Home
- LVTX vs BOWN Comparison
LVTX vs BOWN Comparison
Compare LVTX & BOWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVTX
- BOWN
- Stock Information
- Founded
- LVTX 2016
- BOWN 2023
- Country
- LVTX Netherlands
- BOWN United States
- Employees
- LVTX N/A
- BOWN N/A
- Industry
- LVTX Biotechnology: Pharmaceutical Preparations
- BOWN
- Sector
- LVTX Health Care
- BOWN
- Exchange
- LVTX Nasdaq
- BOWN Nasdaq
- Market Cap
- LVTX 34.2M
- BOWN 36.1M
- IPO Year
- LVTX 2021
- BOWN 2023
- Fundamental
- Price
- LVTX $1.25
- BOWN $7.57
- Analyst Decision
- LVTX Hold
- BOWN
- Analyst Count
- LVTX 3
- BOWN 0
- Target Price
- LVTX $3.17
- BOWN N/A
- AVG Volume (30 Days)
- LVTX 72.6K
- BOWN 373.1K
- Earning Date
- LVTX 03-28-2025
- BOWN 01-01-0001
- Dividend Yield
- LVTX N/A
- BOWN N/A
- EPS Growth
- LVTX N/A
- BOWN N/A
- EPS
- LVTX N/A
- BOWN 0.39
- Revenue
- LVTX $11,982,000.00
- BOWN N/A
- Revenue This Year
- LVTX $16.68
- BOWN N/A
- Revenue Next Year
- LVTX N/A
- BOWN N/A
- P/E Ratio
- LVTX N/A
- BOWN $20.62
- Revenue Growth
- LVTX 77.01
- BOWN N/A
- 52 Week Low
- LVTX $0.85
- BOWN $2.71
- 52 Week High
- LVTX $3.57
- BOWN $11.00
- Technical
- Relative Strength Index (RSI)
- LVTX 49.47
- BOWN 64.25
- Support Level
- LVTX $1.20
- BOWN $6.50
- Resistance Level
- LVTX $1.36
- BOWN $8.89
- Average True Range (ATR)
- LVTX 0.08
- BOWN 1.04
- MACD
- LVTX -0.02
- BOWN 0.36
- Stochastic Oscillator
- LVTX 29.41
- BOWN 74.65
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.
About BOWN Bowen Acquisition Corp
Bowen Acquisition Corp is a blank check company.